Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine.
A chronic schizophrenic patient developed a fatal agranulocytosis 1 month after beginning to take carbamazepine for aggression. Routine hematological monitoring was not carried out. This case highlights the need for psychiatrists' increased awareness of the possible hematological complications of carbamazepine.